Brain Cancer Trial, Recruiting NCT07627334 Sponsor: Medical University of Vienna Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07627334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are generally able to carry out your daily activities, even if you have some limitations (your doctor rates your physical ability as 0, 1, or 2 on a standard scale)
  • You have been recently diagnosed with a specific type of brain tumour called glioblastoma (IDH-wildtype), classified according to 2021 international guidelines
  • Your tumour has a specific genetic feature called an "unmethylated MGMT promoter," as tested by your local medical team
  • Living cancer cells from your tumour have been successfully grown in a lab for drug testing as part of one of several specific Austrian research studies (confirm with trial site)
  • You are planned to receive a shorter course of radiotherapy, with or without a chemotherapy drug called temozolomide
  • You are able and willing to give written consent to take part in the trial

Who may not be able to join:

  • You are currently taking part in another clinical trial that involves a treatment
  • You have, or have had within the last five years, another type of cancer — although some early-stage or non-spreading cancers within the last three years may still be acceptable (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You currently have an active hepatitis B or hepatitis C infection — although people with a past or resolved hepatitis B infection, or a resolved hepatitis C infection confirmed by a specific blood test, may still be eligible (confirm with trial site)
  • You have an HIV infection that is not well managed — people with HIV that is well controlled on stable medication, with good blood counts and no recent serious infections, may still be eligible (confirm with trial site)
  • You are unable or unwilling to follow the requirements of the trial, as judged by the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 January 2028

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Percentage of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov